ARCHIVES

Monoclonal Antibody Improves AML Response To Therapy

This article is from The Cancer Letter archive.

Vol. 25 No. 7 | July 26, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Discuses Establishment of Standards for Showing Equivalence

December 17, 1999

Letter: The Lesson From Dana-Farber

July 28, 1995

NIH Alternative Medicine Office Releases RFA For Grant Awards

April 9, 1993

Bypass Budget Going to White House Next Month Will Seek Optimal Funding for Cancer Program

August 22, 1980

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

Limit On Number Of Surgery Planning Grants Lifted After DCT Board Pressure

March 19, 1982